GGrantIndex
Sort

27,075 grants matching cholesterol

Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV

$805,830
Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2009 · HL

The Genetic and Molecular Basis of Cholesterol Efflux

$805,682
Anand Kumar Rohatgi · Ut Southwestern Medical Center · R01 · FY2019 · HL

Structure-Function Relationships in Presenilin/y-Secretase

$805,037
Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2010 · AG

Personalized genetic profiles of risk and resilience in Alzheimer's and vascular diseases

$804,525
Alexander M Kulminski · Duke University · R01 · FY2020 · AG

Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches

$804,498
Andrew Edward Moran · Columbia University Health Sciences · R01 · FY2020 · HL

Imaging the Invisible with No Labels: A Major Opportunity in Biology and Medicine

$804,464
Xiaoliang Sunney Xie · Harvard University · R01 · FY2010 · EB

Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism

$804,378
Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA

Impact of Interventions on Future Trends in Subnational Burden of Cardiovascular Diseases in the US

$803,986
Gregory Andrew Roth · University Of Washington · R01 · FY2022 · HL

Epigenetic fine-mapping of cardiometabolic disease loci in the human liver

$803,873
Christopher David Brown · University Of Pennsylvania · R01 · FY2017 · HL

Functions of KSHV microRNAs and circular RNAs

$803,668
Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Lipid nanoparticle adjuvants for mRNA vaccines: composition-function relation and mechanism of action

$803,514
Norbert Pardi · University Of Pennsylvania · R01 · FY2025 · AI

Imaging the Invisible with No Labels: A Major Opportunity in Biology and Medicine

$803,390
Xiaoliang Sunney Xie · Harvard University · R01 · FY2009 · EB

HLD-mediated cholesterol efflux and plaque inflammation in MESA

$802,978
Steven J Shea · Columbia University Health Sciences · R01 · FY2018 · HL

High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux

$802,905
Richard I Sherwood · Brigham And Women'S Hospital · R01 · FY2022 · HL

Control of Cholesterol Metabolism --Bile Acid Transport

$802,901
University Of Texas Sw Med Ctr/Dallas · R01 · FY2005 · HL

Genes, Hormones & Environment in an Ovarian Cancer Model

$802,843
Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2006 · CA

Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes

$802,834
Julia Tcw · Boston University Medical Campus · R01 · FY2024 · AG

Sigma-1 Receptor Radioligand for Translational Research in Alzheimer's Disease

$802,472
Yiyun Henry Huang · Yale University · R01 · FY2025 · AG

Inflammation-resolution impairments in aging and atherosclerosis

$802,138
Gabrielle Fredman · Albany Medical College · R01 · FY2023 · HL

Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis

$801,758
Gary K Owens · University Of Virginia · R01 · FY2025 · HL

Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis

$801,758
Gary K Owens · University Of Virginia · R01 · FY2023 · HL

HDL Proteins and Coronary Heart Disease

$801,672
Frank M Sacks · Harvard School Of Public Health · R01 · FY2016 · HL

Development of non-toxic amphotericin B derivatives targeting invasive fungal infections

$801,630
Martin D Burke · University Of Illinois At Urbana-Champaign · R01 · FY2018 · AI

Control of Cholesterol Metabolism --Bile Acid Transport

$801,514
John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2007 · HL

Foam cells as drug targets in tuberculosis

$801,457
Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2019 · HL